NASDAQ:ASPX (ASPX) (ASPX) Stock Price, News & Analysis → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Free ASPX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume1.02 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (ASPX) alerts: Email Address Ad Gold Safe ExchangeThe “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! About (ASPX) Stock (NASDAQ:ASPX)Auspex Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for people with movement disorders and other rare diseases, including orphan diseases. Its pipeline includes product candidates to address unmet medical needs in hyperkinetic movement disorders, such as chorea (abnormal involuntary movements) associated with Huntington's disease, an orphan disease, tardive dyskinesia and Tourette syndrome in the pediatric population, which is an orphan disease, as well as other orphan indications. Its lead product candidate is SD-809, which is a small molecule inhibitor of vesicular monoamine transporter 2 (VMAT2). Its other programs include SD-560, SD-1077 and SD-254.Read More Ad Gold Safe ExchangeThe “Perfect Storm” for GoldGold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! ASPX Stock News HeadlinesApril 18, 2024 | msn.comMinnesota investigators ask for help locating fugitiveApril 18, 2024 | msn.comAppeal to find fugitive accused pedophile who may be loose in MinnesotaApril 18, 2024 | DTI (Ad)Biden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereApril 18, 2024 | msn.comChatGPT shows promise in polypharmacy managementApril 18, 2024 | msn.comBullying bill moves forward in the Missouri Legislature; teacher pay bill passesApril 18, 2024 | msn.comNanocellulose Is Increasingly Safe for Our Seas, According to Findings From a Study Conducted on MusselsApril 18, 2024 | msn.com2024 Louisville homicides: Man charged with murder in connection to Preston Highway crashApril 17, 2024 | msn.comGuest Commentary | Why serving on civil grand jury benefits allApril 18, 2024 | DTI (Ad)Biden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereApril 17, 2024 | msn.comSPOTTED: Police release pictures of minivan connected to South Side business vandalsApril 17, 2024 | msn.comAudit of Oregon Department of Environmental Quality recommends better strategic planningApril 17, 2024 | msn.comButler County Auditor’s Office website sees ‘unusual activity’April 17, 2024 | finance.yahoo.comWestlake Announces First Quarter 2024 Earnings Conference CallApril 17, 2024 | msn.comEarth Day activities happening in Oakland CountyApril 17, 2024 | finance.yahoo.comElanco Confirms Date and Conference Call for First Quarter 2024 Financial Results AnnouncementApril 17, 2024 | seatrade-maritime.comNTSB investigations in the spotlight with Dali bridge collisionApril 17, 2024 | msn.comSocial housing tenants' anger over rats and leaksApril 16, 2024 | msn.comButler County auditor's website goes offline as security precautionApril 16, 2024 | msn.comPioneer Memorial Park grows into an arboretumApril 16, 2024 | msn.com2024 Louisville homicides: Man dies after shooting in the Shively neighborhoodApril 15, 2024 | msn.comWisconsin Allows Noncitizens to Get IDs to Vote?April 15, 2024 | msn.comMore than Mediterranean: Exploring and acknowledging the benefits of diverse cultural and nutritional heritagesApril 15, 2024 | baystreet.caTesla to Announce LayoffsApril 15, 2024 | msn.comModerate vitamin E, C, and β-carotene intake reduces type 2 diabetes riskApril 14, 2024 | msn.comLiverpool’s title chances suffer huge blow as Crystal Palace win at AnfieldApril 14, 2024 | reuters.comIndia's forex reserves rise for seventh consecutive week to record highApril 14, 2024 | msn.comOakland County community calendar April 14 and beyondSee More Headlines Receive ASPX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (ASPX) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/16/2015Today4/18/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:ASPX CUSIPN/A CIK1454189 WebN/A Phone+1-858-5582400FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report ASPX Stock Analysis - Frequently Asked Questions How were (ASPX)'s earnings last quarter? (ASPX) (NASDAQ:ASPX) released its quarterly earnings results on Monday, March, 16th. The biopharmaceutical company reported ($0.74) EPS for the quarter, missing the consensus estimate of ($0.59) by $0.15. What other stocks do shareholders of (ASPX) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (ASPX) investors own include Achillion Pharmaceuticals (ACHN), Alnylam Pharmaceuticals (ALNY), GoPro (GPRO), Ambarella (AMBA), Alkermes (ALKS), Align Technology (ALGN), Akebia Therapeutics (AKBA), Agios Pharmaceuticals (AGIO), ACADIA Pharmaceuticals (ACAD) and Arbutus Biopharma (ABUS). This page (NASDAQ:ASPX) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTIBiden replacement revealed?Paradigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceTop 5 AI Stocks to Buy for 2024Market Moving TrendsHow Biden has already won 2024Porter & CompanyOptions trading has suddenly become more reliable.Eagle Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (ASPX) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.